The top international medical journal BMJ reported a case of a team from the Ninth Hospital successfully treating difficult cysts with absolute ethanol.
Recently, the Interventional Department team of Shanghai Ninth People's Hospital published a clinical case report in the British Medical Journal, one of the four top international clinical journals.
Dr. Yang Xitao from the Interventional Department of the Ninth Hospital is the corresponding author of the article, and doctoral student Li Xinyu is the first author of the article. The article introduces a case of a female with autosomal dominant polycystic kidney disease who was admitted to the Interventional Department of the Ninth Hospital. The patient suffered from severe abdominal distension, chest tightness and shortness of breath after exercise, which seriously affected her daily life. She had not received feasible drug treatment or medical treatment in multiple places. Surgical options.
Autosomal dominant polycystic kidney disease is a hereditary disease that often manifests as polycystic kidneys, polycystic liver, and polycystic pancreas. Its clinical symptoms mostly appear in patients aged 30 to 40 years old, and often manifest as abdominal pain and bloating. In addition, , clinical symptoms such as hypertension, hematuria and recurrent urinary tract infections may also occur. If it does not receive active and effective treatment, it can develop into liver and kidney failure, which is life-threatening. According to statistics, nearly half of patients with autosomal dominant polycystic kidney disease may progress to liver and kidney failure.
Minimally invasive methods based on absolute ethanol sclerotherapy can significantly improve patients' symptoms, inhibit disease progression, relieve patients' pain, avoid or reduce the risk of liver and kidney failure, and improve patients' quality of life. In response to the difficulties of this case, the interventional team of the Ninth Hospital discussed in detail, customized a personalized plan, and finally confirmed the dual-channel treatment of targeted arterial embolization combined with local aspiration and absolute ethanol sclerosis to achieve rapid devascularization and shrinkage of cystic lesions. . This method has the advantages of small trauma, no scars, and quick recovery. Immediately after the operation, the patient's abdominal distension symptoms improved significantly, his daily life gradually returned to normal, and he returned to work.
Over the years, the Interventional Department of the Ninth Hospital has carried out a large number of interventional treatments for difficult and difficult cases based on the concepts of small trauma, high efficacy, and early recovery, such as targeted arterial chemoembolization, percutaneous tumor ablation, intertissue radioactive seed implantation, vascular and non-invasive treatment, etc. Vascular stent angioplasty, percutaneous bone/vertebral cementoplasty, transinternal jugular vein intrahepatic portosystemic shunt, etc., for polycystic liver and kidney disease and its complications, complications after liver transplantation, and cirrhosis and portal hypertension. We have established unique personalized treatment plans for difficult problems such as portal vein thrombosis, gastrointestinal bleeding, and mid-to-late stage malignant tumors, which can significantly improve patient prognosis and quality of life.
Among them, absolute ethanol treatment has provided good curative effect for a large number of complex and difficult patients, and has successfully accumulated experience in the treatment of hemangiomas and vascular malformations. At the same time, it has successfully established an interventional diagnosis and treatment system with absolute ethanol as its brand feature and integrated diagnosis, treatment and rehabilitation. As a national key clinical specialty and a leading domestic and world-leading vascular diagnosis and treatment center, it has established an alliance with European and American vascular disease centers. With a close long-term cooperative relationship, he has published more than 50 SCI papers and received support from a number of National Natural Science Foundation of China projects.